Calcifediol

Generic Name
Calcifediol
Brand Names
Rayaldee
Drug Type
Small Molecule
Chemical Formula
C27H44O2
CAS Number
19356-17-3
Unique Ingredient Identifier
T0WXW8F54E
Background

The major circulating metabolite of vitamin D3 (cholecalciferol). It is produced in the liver and is the best indicator of the body's vitamin D stores. It is effective in the treatment of rickets and osteomalacia, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties.

Indication

Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or...

Associated Conditions
Secondary Hyperparathyroidism (SHPT)
Associated Therapies
-

Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19).

Recruiting
Conditions
Interventions
First Posted Date
2024-02-28
Last Posted Date
2024-02-28
Lead Sponsor
Complejo Hospitalario Universitario de Albacete
Target Recruit Count
275
Registration Number
NCT06279910
Locations
🇪🇸

Complejo Hospitalario Universitario de la Gerencia de Atención Integrada (GAI) de Albacete, Albacete, Spain

🇪🇸

Maimónides Biomedical Research Institute of Córdoba (IMIBIC)., Cordoba, Spain

Calcifediol in the Treatment of COVID 19

First Posted Date
2023-04-19
Last Posted Date
2023-04-28
Lead Sponsor
Maimónides Biomedical Research Institute of Córdoba
Target Recruit Count
728
Registration Number
NCT05819918
Locations
🇪🇸

Hospital Universitario Reina Sofia, Cordoba, Córdoba, Spain

Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19

First Posted Date
2020-09-16
Last Posted Date
2024-05-28
Lead Sponsor
OPKO Health, Inc.
Target Recruit Count
171
Registration Number
NCT04551911
Locations
🇺🇸

OPKO Investigative Site, Omaha, Nebraska, United States

25-Hydroxyvitamin D Pharmacokinetic Study

First Posted Date
2018-01-17
Last Posted Date
2020-06-04
Lead Sponsor
Boston University
Target Recruit Count
16
Registration Number
NCT03401541
Locations
🇺🇸

Solomon Carter Fuller Mental Health Center, Boston, Massachusetts, United States

Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury

First Posted Date
2016-11-11
Last Posted Date
2022-02-03
Lead Sponsor
David Leaf
Target Recruit Count
150
Registration Number
NCT02962102
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD)

Phase 4
Completed
Conditions
Interventions
First Posted Date
2016-06-20
Last Posted Date
2017-06-16
Lead Sponsor
MurciaSalud
Target Recruit Count
112
Registration Number
NCT02805907
Locations
🇪🇸

Servicio Murciano de Salud, Murcia, Spain

Effect of Vitamin D on Ventricular Remodeling in Patients With Acute Myocardial Infarction (VITDAMI)

Phase 3
Completed
Conditions
Interventions
First Posted Date
2015-09-14
Last Posted Date
2023-10-03
Lead Sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Target Recruit Count
109
Registration Number
NCT02548364
Locations
🇪🇸

Hospital Puerta de Hierro, Majadahonda, Madrid, Spain

🇪🇸

Hospital Rey Juan Carlos, Mostoles, Madrid, Spain

🇪🇸

Hospital de Fuenlabrada, Fuenlabrada, Madrid, Spain

and more 4 locations

Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.

First Posted Date
2013-09-11
Last Posted Date
2018-11-19
Lead Sponsor
Fundación Senefro
Target Recruit Count
148
Registration Number
NCT01939977
Locations
🇪🇸

Hospital Universitari Germans Trias I Pujol de Badalona, Badalona, Barcelona, Spain

🇪🇸

Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain

🇪🇸

Hospital Puerta Del Mar, Cádiz, Spain

and more 13 locations
© Copyright 2024. All Rights Reserved by MedPath